Parkman Healthcare Partners LLC has disclosed 90 total holdings in their latest 13F filing with the SEC for the portfolio
date of 2024-06-30. The current portfolio value is calculated to be $747.00 Mil. The turnover rate is 22%.
In Parkman Healthcare Partners LLC's current portfolio as of 2024-06-30, the top 5 holdings are
Boston Scientific Corp (BSX), Insulet Corp (PODD), United Therapeutics Corp (UTHR), Eli Lilly and Co (LLY), The Cooper Companies Inc (COO), not including call and put options.
Parkman Healthcare Partners LLC did not buy any new stocks in the current portfolio.
Please visit the "Current Portfolio" tab to see the current and past 13F holdings for Parkman Healthcare Partners LLC, as well as holding map,
valuations for each stock, which positions are undervalued, have low PE Ratios, are considered high quality and recently traded at
52-week lows, etc.
Please visit the "Stock Picks" tab to see the latest guru trades and stock picks for Parkman Healthcare Partners LLC, which include data from
13F quarterly reports, 13D/G beneficial ownership reports and form 4 insider ownership change reports.
Please visit the "Summary" page to see the top 10 holdings, recent stock picks, performance, sector / industry breakdown details, as well as past holding history summary for Parkman Healthcare Partners LLC.